Moderna to build mRNA vaccine manufacturing facility in Kenya | ANG
  • September 25, 2023

Guinea´s leader defends coups in Africa and rebuffs the West, saying things must change

The recent coups in Africa are attempts by militaries to save their countries from presidents’ “broken promises,” the head of Guinea´s junta said Thursday as he rebuffed the West for boxing …

Nigerians rally in Lagos after death of Afrobeats star

Hundreds of Nigerians rallied in Lagos Thursday to demand an investigation into last week’s death of an upcoming singer, whose sudden demise has fired up the country’s Afrobeats world. MohBad, whose …

Mozambique and U.S. seek to deepen defence, security ties

Mozambican President Filipe Jacinto Nyusi was welcomed Friday (Sep. 22) by the U.S. Secretary of Defence to discuss the nations’ bilateral defence relationship and security cooperation. Since 2017, Mozambique’s northernmost province …

Pharmaceutical giant Moderna has signed a memorandum of understanding (MOU) with Kenya’s government for its first mRNA vaccine manufacturing facility in Africa.

In a statement on Monday (07 March), the company said its goal is to produce up to 500 million doses of vaccines a year for the continent, with a focus on drug substance manufacturing, though the facility could be expanded to include fill-and-finish work.

“In parallel, Moderna is also working on plans to allow it to fill doses of its COVID-19 vaccine in Africa as early as 2023, subject to demand,” the company said.

Currently, the least vaccinated region in the world against the coronavirus, Africa relies on imports for about 99% of its vaccine needs, according to the World Health Organization.

In October, Senegal and Rwanda signed an agreement with BioNTech for the construction of its first start-to-finish factories to make mRNA vaccines in Africa.

The novel mRNA process uses the genetic code for the spike protein of the coronavirus and is thought to trigger a better immune response than traditional vaccines. Scientists hope the technology, which is easier to scale up than traditional vaccine methods, might ultimately be used to make vaccines against other diseases, including malaria.

Leave a Reply

Your email address will not be published. Required fields are marked *